BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35321621)

  • 1. Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China.
    Ji M; Huang Z; Ren J; Wagner AL
    Hum Vaccin Immunother; 2022 Nov; 18(5):2043025. PubMed ID: 35321621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2014.
    Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Kolasa M
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(33):889-96. PubMed ID: 26313470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Constenla D; Liu T
    Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Baine Y; Cheuvart B; Silerova M; Mesaros N
    Hum Vaccin Immunother; 2019; 15(2):327-338. PubMed ID: 30252603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
    Clark A; Jauregui B; Griffiths U; Janusz CB; BolaƱos-Sierra B; Hajjeh R; Andrus JK; Sanderson C
    Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage and Equity of Childhood Vaccines in China.
    Zhang H; Lai X; Mak J; Sriudomporn S; Zhang H; Fang H; Patenaude B
    JAMA Netw Open; 2022 Dec; 5(12):e2246005. PubMed ID: 36484985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China.
    Lyu Y; Lai X; Ma Y; Fang H
    Infect Dis Poverty; 2023 Oct; 12(1):91. PubMed ID: 37805654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2015.
    Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Dietz V
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(39):1065-1071. PubMed ID: 27711036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of New Vaccine Introduction - Worldwide, September 2016.
    Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.
    Black S
    Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
    Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
    Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of coverage, compliance and determinants of uptake in a publicly funded rotavirus vaccination programme: a retrospective cohort study.
    Rafferty E; Guo X; McDonald B; Svenson LW; MacDonald SE
    BMJ Open; 2019 Nov; 9(11):e031718. PubMed ID: 31678951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low vaccination coverage of pneumococcal conjugate vaccines (PCVs) in Shanghai, China: A database analysis based on birth cohorts from 2012 to 2020.
    Wang J; Wu QS; Lu J; Ni YH; Zhou F
    Vaccine; 2021 Oct; 39(42):6189-6194. PubMed ID: 34538698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
    Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
    J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Challenge of Achieving Immunity Through Multiple-Dose Vaccines in Madagascar.
    Jones FK; Mensah K; Heraud JM; Randriatsarafara FM; Metcalf CJE; Wesolowski A
    Am J Epidemiol; 2021 Oct; 190(10):2085-2093. PubMed ID: 34023892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of administration and attitudes about pneumococcal, Haemophilus influenzae type b and rotavirus vaccines among pediatricians in India: a national survey.
    Gargano LM; Thacker N; Choudhury P; Weiss PS; Pazol K; Bahl S; Jafari HS; Arora M; Orenstein WA; Hughes JM; Omer SB
    Vaccine; 2012 May; 30(24):3541-5. PubMed ID: 22475859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
    Gargano LM; Hajjeh R; Cookson ST
    Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.